Historical record - last NADAC effective date: 1/1/2019
Product Information
MEPRON 750 MG/5 ML SUSPENSION is a brand product labeled by GlaxoSmithKline LLC, priced at $6.8952 per ML under NDC 00173066518. Its NADAC has been published 313 times since Nov 28, 2013.
FDA first approved this application on Feb 8, 1995. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the atovaquone market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
750 mg/5mL
Manufacturer
GlaxoSmithKline LLCNDC
00173066518
Classification
Brand
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
1/1/2019
Active Ingredients
ATOVAQUONEApproval Type
New Drug (NDA)
FDA Application
NDA020500FDA Approved
2/8/1995
TE Code
AB
On Market Since
2/28/1995
Pharmacological Classes
Price Statistics
The NADAC for MEPRON 750 MG/5 ML SUSPENSION has been published 313 times since Nov 28, 2013, and over the history we have for it it has risen 29.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8952 per ML |
|---|---|
| All-time high | $6.8952 (Jan 15, 2020) |
| All-time low | $5.3450 (Nov 28, 2013) |
| Median price | $6.3756 |
| Average price | $6.2541 |
| Largest weekly change | +10.0% (Jan 15, 2014) |
| Weeks tracked | 313 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
+29.0%
Last surveyed Jan 15, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 89% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
GlaxoSmithKline LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
atovaquone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antimalarial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEPRON 750 MG/5 ML SUSPENSION?
The current National Average Drug Acquisition Cost (NADAC) for MEPRON 750 MG/5 ML SUSPENSION, manufactured by GlaxoSmithKline LLC, is $6.8952 per ML (NDC 00173066518), effective Jan 15, 2020.
How has the price of MEPRON 750 MG/5 ML SUSPENSION changed over time?
Over the history we have for it, the NADAC for MEPRON 750 MG/5 ML SUSPENSION has risen 29.0%. It has been tracked across 313 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for MEPRON 750 MG/5 ML SUSPENSION?
Since Nov 28, 2013, the NADAC for MEPRON 750 MG/5 ML SUSPENSION has ranged from a low of $5.3450 (Nov 28, 2013) to a high of $6.8952 (Jan 15, 2020), with a median of $6.3756 per ML.
Are there cheaper alternatives to MEPRON 750 MG/5 ML SUSPENSION?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATOVAQUONE 750 MG/5 ML SUSP, is $0.7668 per ML — about 89% below MEPRON 750 MG/5 ML SUSPENSION.
Who manufactures MEPRON 750 MG/5 ML SUSPENSION?
MEPRON 750 MG/5 ML SUSPENSION (NDC 00173066518) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.